Given the rarity of the disease there is a need to establish a registry of SCN5A variants associated with MEPPC and DCM, in order to improve knowledge on clinical symptoms and pharmaceutical management. The gene discussed is SCN5A; the disease is familial dilated cardiomyopathy.